Erhard Trillingsgaard Næss-Schmidt
Aarhus University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Hotspot
Dive into the research topics where Erhard Trillingsgaard Næss-Schmidt is active.
Publication
Featured researches published by Erhard Trillingsgaard Næss-Schmidt.
Journal of Cerebral Blood Flow and Metabolism | 2013
Leif Østergaard; Rasmus Aamand; Sanja Karabegovic; Anna Tietze; Jakob Udby Blicher; Irene Klærke Mikkelsen; Nina Iversen; Niels Jørgen Secher; Thorbjørn S Engedal; Mariam Anzabi; Eugenio Gutiérrez Jiménez; Changsi Cai; Klaus Ulrik Koch; Erhard Trillingsgaard Næss-Schmidt; Annette Obel; Niels Juul; Mads Rasmussen; Jens Christian Sørensen
The mortality after aneurysmal subarachnoid hemorrhage (SAH) is 50%, and most survivors suffer severe functional and cognitive deficits. Half of SAH patients deteriorate 5 to 14 days after the initial bleeding, so-called delayed cerebral ischemia (DCI). Although often attributed to vasospasms, DCI may develop in the absence of angiographic vasospasms, and therapeutic reversal of angiographic vasospasms fails to improve patient outcome. The etiology of chronic neurodegenerative changes after SAH remains poorly understood. Brain oxygenation depends on both cerebral blood flow (CBF) and its microscopic distribution, the so-called capillary transit time heterogeneity (CTH). In theory, increased CTH can therefore lead to tissue hypoxia in the absence of severe CBF reductions, whereas reductions in CBF, paradoxically, improve brain oxygenation if CTH is critically elevated. We review potential sources of elevated CTH after SAH. Pericyte constrictions in relation to the initial ischemic episode and subsequent oxidative stress, nitric oxide depletion during the pericapillary clearance of oxyhemoglobin, vasogenic edema, leukocytosis, and astrocytic endfeet swelling are identified as potential sources of elevated CTH, and hence of metabolic derangement, after SAH. Irreversible changes in capillary morphology and function are predicted to contribute to long-term relative tissue hypoxia, inflammation, and neurodegeneration. We discuss diagnostic and therapeutic implications of these predictions.
Journal of Cerebral Blood Flow and Metabolism | 2014
Leif Østergaard; Thorbjørn S Engedal; Rasmus Aamand; Ronni Mikkelsen; Nina Iversen; Maryam Anzabi; Erhard Trillingsgaard Næss-Schmidt; Kim Ryun Drasbek; Vibeke Bay; Jakob Udby Blicher; Anna Tietze; Irene Klærke Mikkelsen; Brian Benjamin Hansen; Sune Nørhøj Jespersen; Niels Juul; Jens Sörensen; Mads Rasmussen
Most patients who die after traumatic brain injury (TBI) show evidence of ischemic brain damage. Nevertheless, it has proven difficult to demonstrate cerebral ischemia in TBI patients. After TBI, both global and localized changes in cerebral blood flow (CBF) are observed, depending on the extent of diffuse brain swelling and the size and location of contusions and hematoma. These changes vary considerably over time, with most TBI patients showing reduced CBF during the first 12hours after injury, then hyperperfusion, and in some patients vasospasms before CBF eventually normalizes. This apparent neurovascular uncoupling has been ascribed to mitochondrial dysfunction, hindered oxygen diffusion into tissue, or microthrombosis. Capillary compression by astrocytic endfeet swelling is observed in biopsies acquired from TBI patients. In animal models, elevated intracranial pressure compresses capillaries, causing redistribution of capillary flows into patterns argued to cause functional shunting of oxygenated blood through the capillary bed. We used a biophysical model of oxygen transport in tissue to examine how capillary flow disturbances may contribute to the profound changes in CBF after TBI. The analysis suggests that elevated capillary transit time heterogeneity can cause critical reductions in oxygen availability in the absence of ‘classic’ ischemia. We discuss diagnostic and therapeutic consequences of these predictions.
Neurorehabilitation and Neural Repair | 2015
Jakob Udby Blicher; Jamie Near; Erhard Trillingsgaard Næss-Schmidt; Charlotte J. Stagg; Heidi Johansen-Berg; Jørgen Feldbæk Nielsen; Leif Østergaard; Yi-Ching Lynn Ho
Background and Objective. γ-Aminobutyric acid (GABA) is the dominant inhibitory neurotransmitter in the brain and is important in motor learning. We aimed to measure GABA content in primary motor cortex poststroke (using GABA-edited magnetic resonance spectroscopy [MRS]) and in relation to motor recovery during 2 weeks of constraint-induced movement therapy (CIMT). Methods. Twenty-one patients (3-12 months poststroke) and 20 healthy subjects were recruited. Magnetic resonance imaging structural T1 and GABA-edited MRS were performed at baseline and after CIMT, and once in healthy subjects. GABA:creatine (GABA:Cr) ratio was measured by GABA-edited MRS. Motor function was measured using Wolf Motor Function Test (WMFT). Results. Baseline comparison between stroke patients (n = 19) and healthy subjects showed a significantly lower GABA:Cr ratio in stroke patients (P < .001) even after correcting for gray matter content in the voxel (P < .01) and when expressing GABA relative to N-acetylaspartic acid (NAA; P = .03). After 2 weeks of CIMT patients improved significantly on WMFT, but no consistent change across the group was observed for the GABA:Cr ratio (n = 17). However, the extent of improvement on WMFT correlated significantly with the magnitude of GABA:Cr changes (P < .01), with decreases in GABA:Cr ratio being associated with better improvements in motor function. Conclusions. In patients 3 to 12 months poststroke, GABA levels are lower in the primary motor cortex than in healthy subjects. The observed association between GABA and recovery warrants further studies on the potential use of GABA MRS as a biomarker in poststroke recovery.
computer assisted radiology and surgery | 2016
Erhard Trillingsgaard Næss-Schmidt; Anna Tietze; Jakob Udby Blicher; Mikkel Steen Petersen; Irene Klærke Mikkelsen; Pierrick Coupé; José V. Manjón; Simon Fristed Eskildsen
PurposeIn both structural and functional MRI, there is a need for accurate and reliable automatic segmentation of brain regions. Inconsistent segmentation reduces sensitivity and may bias results in clinical studies. The current study compares the performance of publicly available segmentation tools and their impact on diffusion quantification, emphasizing the importance of using recently developed segmentation algorithms and imaging techniques.MethodsFour publicly available, automatic segmentation methods (volBrain, FSL, FreeSurfer and SPM) are compared to manual segmentation of the thalamus and hippocampus imaged with a recently proposed T1-weighted MRI sequence (MP2RAGE). We evaluate morphometric accuracy on 22 healthy subjects and impact on diffusivity measurements obtained from aligned diffusion-weighted images on a subset of 10 subjects.ResultsCompared to manual segmentation, the highest Dice similarity index of the thalamus is obtained with volBrain using a local library (
Brain Injury | 2017
Erhard Trillingsgaard Næss-Schmidt; Jakob Udby Blicher; Simon Fristed Eskildsen; Anna Tietze; Brian Benjamin Hansen; Peter William Stubbs; Sune Nørhøj Jespersen; Leif Østergaard; Jørgen Feldbæk Nielsen
Brain Injury | 2018
Erhard Trillingsgaard Næss-Schmidt; Jakob Udby Blicher; Anna Tietze; Charlotte Ulrikka Rask; Susanne Wulff Svendsen; Andreas Schröder; Mille Møller Thastum; Astrid Tuborgh; Oana-Veronica Frederiksen; Leif Østergaard; Simon Fristed Eskildsen; Brian Benjamin Hansen; Sune Nørhøj Jespersen; Jørgen Feldbæk Nielsen
M=0.913
First International Workshop on Patch-based Techniques in Medical Images (Patch-MI 2015) | 2015
Erhard Trillingsgaard Næss-Schmidt; Anna Tietze; Irene Klærke Mikkelsen; Mikkel Steen Petersen; Jakob Udby Blicher; Pierrick Coupé; José V. Manjón; Simon Fristed Eskildsen
Heliyon | 2017
Erhard Trillingsgaard Næss-Schmidt; Morten Morthorst; Asger Roer Pedersen; Jørgen Feldbæk Nielsen; Peter William Stubbs
M=0.913,
Journal of the Neurological Sciences | 2013
Jakob Udby Blicher; Jamie Near; Erhard Trillingsgaard Næss-Schmidt; Leif Østergaard; Heidi Johansen-Berg; Y.-C.L. Ho
NeuroRehabilitation | 2018
Mille Moeller Thastum; Charlotte Ulrikka Rask; Erhard Trillingsgaard Næss-Schmidt; Jens Soendergaard Jensen; Oana-Veronica Frederiksen; Astrid Tuborgh; Susanne Wulff Svendsen; Joergen Feldbaek Nielsen; Andreas Schröder
\hbox {SD}=0.014